Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

135.11 +0.07 (+0.05%)

Streaming Delayed Price Updated: 9:55 AM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023 ↗

July 18, 2023

Via Benzinga

Masimo Plummets To Five-Year Low On Light Sales, 'Longer-Term' Challenges Persist ↗

July 18, 2023

The company works primarily in health care, but its non-health care efforts are floundering.

Via Investor's Business Daily

Why Masimo Shares Are Dipping Today ↗

July 18, 2023

Masimo Corp (NASDAQ: MASI) shares are trading lower after the company reported

Via Benzinga

CMG Stock Alert: Chipotle Announces International Expansion Plan ↗

July 18, 2023

Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 18, 2023

Via Benzinga

Why Is CEL-SCI (CVM) Stock Down 23% Today? ↗

July 18, 2023

CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.

Via InvestorPlace

Why Is Masimo (MASI) Stock Down 30% Today? ↗

July 18, 2023

Masimo (MASI) stock is taking a beating on Tuesday after the patient monitoring tech company released preliminary earnings for Q2 2023.

Via InvestorPlace

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗

July 18, 2023

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's...

Via Benzinga

Masimo Analysts Cut Their Forecasts Following Preliminary Q2 Results ↗

July 18, 2023

Masimo Corporation (NASDAQ: MASI) reported weak preliminary revenue results for the second quarter.

Via Benzinga

Microsoft To Rally Around 16%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

July 18, 2023

B of A Securities boosted the price target for Camtek Ltd. (NASDAQ: CAMT) from $30 to $50. B of A Securities analyst Vivek Arya upgraded the stock from Neutral to Buy. Camtek shares rose 1.8% to $44.02...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 18, 2023

It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning.

Via InvestorPlace

Nasdaq, S&P 500 Futures Dip Ahead of Big Bank Earnings, Retail Sales Data: Why This Analyst Stays Cautious About Tech Sector ↗

July 18, 2023

Via Benzinga

Masimo, Acumen Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 18, 2023

U.S. stock futures traded mixed this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday ↗

July 18, 2023

With U.S. stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 17, 2023

Via Benzinga

Masimo Announces Preliminary Second Quarter 2023 Revenue Results

July 17, 2023

From Masimo Corporation

Via Business Wire

Analyst Is Bullish On Masimo Despite Proxy Overhang Concerns - Here's Why ↗

July 10, 2023

Wells Fargo initiated coverage on Masimo Corporation (NASDAQ: MASI) with an Equal Weight rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 10, 2023 ↗

July 10, 2023

Via Benzinga

Politan Announces Shareholders Have Overwhelmingly Elected Both Its Director Nominees to Masimo's Board

June 26, 2023

From Politan Capital Management

Via Business Wire

Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients

June 22, 2023

From Masimo

Via Business Wire

Masimo and Clinton Foundation Host Roundtable Addressing Overdose and Addiction Crisis

June 21, 2023

From Masimo

Via Business Wire

Masimo Board of Directors Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card

June 20, 2023

From Masimo Corporation

Via Business Wire

Masimo Expands Into the Personalized Hearables Market with Denon PerL™ True Wireless Earbuds, Featuring Masimo Adaptive Acoustic Technology™ (AAT™)

June 20, 2023

From Masimo

Via Business Wire

Leading Proxy Advisory Firm Glass Lewis Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees

June 15, 2023

From Politan Capital Management

Via Business Wire

Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees

June 13, 2023

From Politan Capital Management

Via Business Wire

Masimo Board of Directors Highlights Value of Company’s Mission-Driven Innovation in Letter to Stockholders

June 13, 2023

From Masimo Corporation

Via Business Wire

Community Health System Expands Use of Multiple Masimo Technologies, System-wide

June 12, 2023

From Masimo

Via Business Wire

Politan Nominees Michelle Brennan and Quentin Koffey Send Letter to Masimo Shareholders

June 12, 2023

From Politan Capital Management

Via Business Wire

Masimo Chairman and CEO Joe Kiani Waives Rights Under Director Change-in-Control Provision

June 06, 2023

From Masimo Corporation

Via Business Wire

Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment

June 08, 2023

From Masimo

Via Business Wire

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.